Contents
The Latest Guidelines for MS Treatment: What You Need to Know
Published: Jan 26, 2024
Multiple sclerosis (MS) treatment is constantly evolving. But what do the latest guidelines say about managing this complex disease? Let's break down the key recommendations.
Early Treatment is Crucial
Current guidelines strongly emphasize the importance of early treatment. Research shows that starting disease-modifying therapy (DMT) as soon as possible after diagnosis can lead to better long-term outcomes. This approach aims to reduce the frequency and severity of relapses, slow disability progression, and limit the formation of new brain lesions.
Personalized Treatment Approaches
Guidelines now recommend a more personalized approach to MS treatment. This involves considering factors like disease severity, individual risk factors, patient preferences, and potential side effects when choosing a DMT. For some patients with highly active disease, starting with a high-efficacy therapy might be recommended. For others, a more conservative approach might be appropriate.
Regular Monitoring and Treatment Adjustment
Current guidelines emphasize the importance of regular monitoring to assess treatment effectiveness. This typically includes clinical evaluations, MRI scans, and sometimes blood tests. If there's evidence of ongoing disease activity (like new relapses or MRI lesions), guidelines recommend considering a switch to a different, potentially more effective DMT.
Frequently Asked Questions
Guidelines suggest yearly MRIs for most patients.
Yes, they recommend exercise, healthy diet, and smoking cessation.
Yes, treatment recommendations vary for different MS types.
Empowering Patients
Understanding these guidelines can help you have more informed discussions with your healthcare team about your MS management.
References
- Rae-Grant A, et al. Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis. Neurology 2018; 90:777.
- Montalban X, et al. ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler 2018; 24:96.
- Freedman MS, et al. Treatment Optimization in Multiple Sclerosis: Canadian MS Working Group Recommendations. Can J Neurol Sci 2020; 47:437.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
Top licensed doctors
Available in all 50 states
Full service care
Prescriptions, referrals & treatment
No insurance needed
All notes available in Doctronic
15-min consultation. No hidden costs.
AI Doctor Visit Required
Please Chat With Our AI Doctor First
Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?